Laboratory Experiences with Griseofulvin  by Schwarz, J. & Loutzenhiser, J.K.
LABORATORY EXPERIENCES WITH GRISEOFTJLVIN
J. SCHWARZ, M.D. AND J. K. LOUTZENHISER, M.D.5
Griseofulvin, an antibiotic derived from
penicillium species has elicited unusual interest
because of its distinctive activity against der-
matophytes, both in vitro and in vivo (1, 3, 5, 6).
The following studies were undertaken to fur-
concentration is probably greater than the actual
content. Therefore the minimal inhibitory con-
centration given in this paper van only approxi-
mate, and represents a truly "minimal" value.
2. The curling of hyphae under the influence
TABLE I
Sensitivity studies with Griseofulvin5
ther evaluate the in vitro inhibitory effects and
the possible toxic effects of this new remedy.
MATERIAL AND METHODS
1. The antibiotic (which is almost insoluble in
water) can be incorporated into solid media but
when serial dilutions are made the calculated
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of griseofulvin was studied by placing small
amounts of the antibiotic several ems. from
already developed fungus colonies on the surface
of the agar plates.
3. Feeding experiments were made in order to
establish the influence of the antibiotic on the
development of infantile mice. Griseofulvin was
incorporated into the animal food in different
concentrations and the weight of the animals
was established at regular intervals.
4. Brain, heart, lungs, liver, spleen, adrenals,
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Key: * j: means 80 pg of Griseofulvin and 160 units of Penicillinase
— = complete inhibition
± = partial inhibition
+ = no inhibition
/ = test not performed
* Variation in the sensitivity of different dermatophytes in our experiments and in comparison with
the data obtained by other authors are related to the poor solubility of griseofulvin and the inherent
difficulty of a constant and reproducible distribution of the antibiotic in solid media.
The readings in this table were recorded after 10 days observation.
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kidneys, testicles or ovaries were examined micro-
scopically after the animals were sacrificed.
5. Penicillinase was added to griseofulvin con-
taining media to study the influence on the anti-
biotic's effect.
Fin. 3. Few hours after addition of griseofulvin
the hyphae become tortuous 53X.
Fin. I. Griseofulvin is placed on the agar close
to the already developed colony of M. canis.
Fin. 4. This increases, producing distortion of
Fin. 2. The terminal hyphae of the "normal" the whole pattern. Notice the numerous lateral
colony are straight 53X. branches 53X.
sc
 2.
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RESULTS TABLE II
Our results are in general agreement with the
% Weight Mg. Grise-experience of others (1) demonstrating selective Absolute Weight, grams Increase in ofulvinRelation toinhibition of dermatophytes and essential ab- Code Initial Weight Intake perkg. of
sence of influence upon the growth of other Letter _____________________________ Actual
pathogenic fungi. Initial After After After After Weight10 days 20 days 10 days 20 days per day
G 16 17.2 22.3 7.5 39 0
II 16.2 18.1 22.9 12 42 0
F 17 22.2 23 30.6 35 15
K 15.4 21 22.7 36 47 16
L 15.5 21 22.5 36 45 29
M 15.8 20 22.1 36 40 66
A 18.8 21.3 22 13 17 125
C' 16.9 18.2 19.6 7 16 125
B 17.6 17.3 17.6 0 0 1350
E 17.2 17 19.8 0 15 1320
D* 18.1 18.7 19.4 0.5 7 1350
* Female, all other groups were males. Each
group consisted of 25 animals. G & H are control
groups getting normal (Rockland) mouse food.
Statistically differences of the initial weight
of the animals were proven not to be significant.
The weight increase on low dosage of griseo-
fulvin after ten days was significantly larger than
5.05 (F 33.2); this was true even after twenty
days albeit to lower degree (F = 16.4). "F values"
from Dixon, W. J. and Massey, F. J. Introduction
to statistical analysis. McGraw-Hill Book Corn-
FIG. 5. Clumping together of the mycelium and pany, New York 1951.
fungistasis 53X.
FIG. 6. The colony shows completely degenerated hyphae (bottom) close to the griseofulvin. The
distant part of the colony (top) shows "curling" 7.9X.
A
__._.
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50
DAY S
GRAPH 1. The percentual increase of weight in infantile mice was plotted after 10 and 20 days feeding
with griseofulvin (see Table II).
Two to three hours after griseofulvin was
placed on agar plates in the vicinity of a well de-
veloped colony of M. canis the straight hyphae
___________________
which were growing in the periphery of the
colony became slightly undulated, developed
curved short lateral branches and finally were
so curled that any resemblance with the original
morphology disappeared. The final state was a
real degeneration and clumping of the mycelial
growth. (Figs. 1—6).
Small amounts of griseofulvin given by mouth
increased considerably the weight after ten
days in infantile mice, whereas large amounts
had definite inhibitory effect on the development.
Intake under 1 gram of griseofulvin per kg. of
body weight per day had no recognizable effect
on spermatogenesis. If 1.3 g. per kg. per day was
given for 18 to 24 days, considerable decrease,
_______________________________ _______
or complete suppression of spermatogenesis re-
sulted. The ovaries did not show comparable
K
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TABLE III
Spermatogenesis
Nor-
mal
Suppression
0
J j
.2
Low diet 19—24 days
(19 animals cx-
amined)*
High diet 12—19 days
(6 animals cx-
amiried)5
High diet 24 days (11
animals exam-
ined)t
14
2
5
3
3
1
1 2
2
3
* 125 mg/kg. per day
f 1.349 g./kg. per day
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damage and looked as healthy as the rest of the
organs even in series with heavy daily intake,
1.3 g. per kg.
If penieillinase was added to the griseofulvin-
containing media no effect of the penicillinase
was noted.
DISCUSSION
Griseofulvia promises to be a major factor in
the treatment of dermatophytes because of its
exquisite fungistatie activity especially against
T. rubrum, which was so difficult to cure in the
past. Mierosporum species and other triehophy-
tons show also impressive inhibitioa of growth
in presence of micrograms of the antibiotic.
The morphologic changes induced by griseo-
fulvin, and named "curling factor" (2, 4) can
be studied within a few hours with the simple
technic described above. Developed colonies
show the curling in more spectacular form than
can be seen incorporating griseofulvin into the
media prior to inoculation.
The weight increase in infantile mice fed with
doses of griseofulvin which were comparable to
therapeutic levels in men was more prominent
than in control animals. Factors similar to the
ones obtained by feeding certain broad spectrum
antibiotics came to mind.
No toxic effects were observed in animals eat-
ing less than 1 gm. griseofulvin per kg. per day.
Toxic levels seemed to be reached over 1 gm.
per kg. per day. Minimal or no weight increase
occurred in those animals.
The only morphologieally detectable lesions
after feeding griseofulvin to mice up to 1.3 gm.
per kg. per day were found in the form of partial
to total suppression of spermatogenesis.
Penieillinase does not destroy the action of
griseofulvin in vitro.
suMMARy
The antibiotic griseofulvin is in vitro inhibitory
for dematophytes even in minimal concentra-
tions.
Toxicity after oral intake of the antibiotic
seems to be limited to influence on spermato-
genesis and occurs only at levels 60 times larger
than the recommended therapeutic dose in men.
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